Open Access

How to improve cardiorenal outcomes in patients with CKD and T2D?

Presentation

About the speaker

Doctor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)
36 presentations
0 follower

4 more presentations in this session

Welcome and introductions.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Insights into the cardiovascular and kidney benefits of MR antagonism: Insights from the FIGARO-DKD and FIDELIO-DKD trials.

Speaker: Professor G. Filippatos (Athens, GR)

Thumbnail

Live Q&A.

Thumbnail

Summary and close.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Access the full session

Exploring the cardiorenal benefits of MR antagonism in CKD and T2D

Speakers: Doctor M. Senni, Professor S. Anker, Professor G. Filippatos, Professor S. Anker
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Proposed treatment after TTM2.

18 March 2022

ACVC Premium Access

TTM2: a game changer?

18 March 2022

ACVC Premium Access

Clinical trial evidence.

18 March 2022

This platform is supported by

logo Novo Nordisk